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Nucleoredoxin (Nrx) is an oxidoreductase of the thioredoxin family of proteins. It was shown to act as a signal transducer in some
pathways; however, so far, no comprehensive analysis of its regulated substrates and functions was available. Here, we used a
combination of two diﬀerent strategies to ﬁll this gap. First, we analyzed the thiol-redox state of the proteome of SH-SY5Y
neuroblastoma cells depleted of Nrx compared to control cells using a diﬀerential thiol-labeling technique and quantitative mass
spectrometry. 171 proteins were identiﬁed with an altered redox state; 161 of these were more reduced in the absence of Nrx.
This suggests functions of Nrx in the oxidation of protein thiols. Second, we utilized the active site mutant Cys208Ser of Nrx,
which stabilizes a mixed disulﬁde intermediate with its substrates and therefore trapped interacting proteins from the mouse
brain (identifying 1710 proteins) and neuronal cell culture extracts (identifying 609 proteins). Proﬁling of the aﬀected biological
processes and molecular functions in cells of neuronal origin suggests numerous functions of Nrx in the redox regulation of
metabolic pathways, cellular morphology, and signal transduction. These results characterize Nrx as a cellular oxidase that itself
may be oxidized by the formation of disulﬁde relays with peroxiredoxins.
1. Introduction
Redox signaling constitutes an essential mechanism for the
regulation of protein function within speciﬁc, rapid, and
highly regulated signaling cascades, comparable to de-/phos-
phorylation. Speciﬁc oxidative modiﬁcations of proteins, for
instance, the formation of allosteric disulﬁdes, are often
attributed to the action of reactive oxygen or nitrogen spe-
cies, most of all hydrogen peroxide (H2O2). Due to the low
rate constants of H2O2 with most protein thiols, however,
this oxidation as well as the reduction of disulﬁdes requires
catalysis by speciﬁc enzymes [1, 2].
Nucleoredoxin (Nrx) is a member of the thioredoxin
(Trx) family of proteins. This family includes various oxido-
reductases, such as Trxs, glutaredoxins (Grxs), peroxiredox-
ins (Prxs), and protein disulﬁde isomerases (PDIs) that
catalyze cellular redox signaling [3]. All these proteins share
a common structural motif, the so-called Trx fold [4]. The
Nrx gene (NXN) encodes a protein of 48 kDa and is ubiqui-
tously expressed [5]. Despite its name, the protein is localized
in both the cytosol and the nucleus [5, 6]. The Nrx protein
contains three Trx domains organized in a structure similar
to those of PDIs that contain three to four Trx domains. The
N- and C-terminal domains of Nrx share a high similarity to
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the b′ domains of PDIs and lack a redox active center. The
central domain, however, contains the dithiol active site motif
Cys-Pro-Pro-Cys and was shown to be active in the insulin
reduction assay [6]. The function of the PDI-like domains in
Nrx is unclear; they may be important for substrate recogni-
tion, i.e., speciﬁc protein-protein interactions.
Up to now, no comprehensive identiﬁcation of potential
Nrx substrates has been presented and only scattered
information on the function of the protein is available.
Two interaction partners that have been identiﬁed are
phosphofructokinase 1 and protein phosphatase 2A [7, 8].
The activity of both proteins is aﬀected through direct
interactions. Nrx also seems to be part of transcriptional
regulation, because it enhances the induction of the three
transcription factors CREB (cAMP response element-
binding protein), NFκB (nuclear factor kappa B), and AP-1
(activator protein-1) [9]. In addition, Nrx was shown to
regulate both the Wnt/PCP (planar cell polarity) and the
Wnt/β-catenin pathway [10, 11]. The latter is inhibited
through Nrx by binding to the basic PDZ domain of
dishevelled (Dvl), thereby suppressing the redirection of the
Wnt-induced signaling. This process is redox-dependent,
because reducing conditions strengthen and oxidizing condi-
tions weaken this protein-protein interaction [10]. Nrx might
not only suppress this pathway but also retain a pool of inac-
tive Dvl by preventing its proteasomal degradation. Binding
of Nrx to the PDZ domain of Dvl prevents the possible inter-
action of Dvl and kelch-like protein 12 (KLHL12), which is
part of an E3 ubiquitin ligase complex and leads to the
ubiquitination and thus degradation of Dvl [12]. This mech-
anism may ensure that the pathway can be rapidly activated
upon Wnt stimulation.
Here, we present the ﬁrst comprehensive analysis of
potential Nrx interaction partners and regulated pathways
using a combination of two diﬀerent strategies. First, we
compared the redox state of the proteome from the human
neuroblastoma cell line SH-SY5Y with cells in which the
expression of Nrx was silenced. The redox state of the thiol
proteome was identiﬁed and quantiﬁed using a diﬀerential
thiol-labeling approach followed by quantitative mass spec-
trometry. Second, we utilized the unique reaction mechanism
of Trx proteins to perform an intermediate trapping experi-
ment using a Cys-Pro-Pro-Ser active site mutant of Nrx.
With this approach, we trapped potential substrates from
the SH-SY5Y cell line, as well as from murine brain tissue.
We identiﬁed more than 50 proteins by all three approaches.
Our ﬁndings imply potential functions of Nrx as an oxidase,
rather than a reductase, in redox regulation of, e.g., metabolic
pathways, cellular morphology, and signal transduction.
2. Material and Methods
2.1. Chemicals and Reagents. Chemicals and enzymes were
purchased from Sigma-Aldrich (St. Louis, USA), unless
otherwise stated, and were of analytical grade or better. Cell
culture media and supplements were purchased from PAN-
Biotech (Aidenbach, Germany) unless otherwise stated.
Antibodies detecting Nrx (16128-1-AP, Proteintech,
Manchester UK), actin (sc-47778, Santa Cruz Biotechnology,
Dallas, USA), Prx1 (LF-MA0214, AbFrontier, Seoul, South
Korea), Prx2 (serum, produced and validated by AG Lillig
[5]), and tyrosine hydroxylase (Millipore MAP318) were
used, as well as horseradish peroxidase-conjugated anti-
rabbit and anti-mouse IgGs (Bio-Rad, Hercules, USA). SDS
PAGE and Western blotting kits and equipment were
purchased from Bio-Rad (Hercules, USA).
2.2. Cloning, Mutagenesis, Protein Expression, and
Puriﬁcation. The open reading frame of Nrx was ampliﬁed
by PCR from mouse cDNA using the oligonucleotides
3′catatgtcgggcttcctggag5′ and 5′ggatccactagatgggctcaggc3′.
Following A-tailing, the PCR product was ligated into
the pGEM-T vector (Promega, Madison, USA) and was
further subcloned by restriction ligation into the expression
plasmid pET15b (Novagen, Darmstadt, Germany). For the
intermediate trapping experiments, the more C-terminal
active site cysteinyl residue of mouse Nrx was exchanged
for a seryl residue (changing the Cys-Pro-Pro-Cys active
site to Cys-Pro-Pro-Ser) by site-directed mutagenesis as
described before in [13] using speciﬁc oligonucleotides
(3′gtgtccacccagccgaagcc5′ and 5′taaggcttcggctgggtggac3′).
Following the sequence analysis, the plasmid was trans-
formed into the E. coli strain BL21(DE3)pRIL. Mouse
Nrx Cys208Ser was expressed as a polyhistidine-tagged
fusion protein in E. coli and was puriﬁed using the immo-
bilized metal aﬃnity chromatography technique and FPLC
(ÄKTAprime, GE Healthcare, Uppsala, Sweden) as described
before in [5]. The expression and puriﬁcation eﬃciency was
analyzed by SDS PAGE.
2.3. Cell Culture and Cell Transfection. SH-SY5Y cells were
cultured in MEM medium without L-glutamine (PAA/GE
Healthcare) supplemented with 2mM L-glutamine and HeLa
cells in DMEM at 37°C and 5% CO2 in a humidiﬁed
atmosphere. Both media were supplemented with 10% FCS
and 0.1mg/ml streptomycin/100U/ml penicillin.
Cells were transiently transfected with speciﬁc siRNA
against Nrx (Eurogentec, Liège, Belgium; test siRNAs:
Ambion, Carlsbad, California) (siNrx A sense: GGAUGA
CAUGACUGACUCCtt, antisense: GGAGUCAGUCAUGU
CAUCCtc; siNrx B sense: GGCCUUUGUGAAUGACUU
Ctt, antisense: GAAGUCAUUCACAAAGGCCtc; siNrx C
sense: GCCGAUAGCUGAGAAAAUCtt, antisense: GAUU
UUCUCAGCUAUCGGCtg), as well as unspeciﬁc, scram-
bled control siRNA (sense: CAUUCACUCAGGUCAUCA
Gtt, antisense: CUGAUGACCUGAGUGAAUGtt) using
electroporation as described before [14]. In brief, 5 · 106
Mio SH-SY5Y cells or 3.5 · 106 HeLa cells were resuspended
in 550μl electroporation buﬀer (21mM HEPES, 137mM
NaCl, 5mM KCl, 0.7mM Na2HPO4, 6mM D-Glucose,
pH7.15), mixed with 15μg siRNA and transfected using
230V, 500Ω, and 1050μF for SH-SY5Y cells or 250V,
500Ω, and 1500μF for HeLa cells. The cells were mixed with
550μl prewarmed FCS and seeded in conditioned medium.
After 72 h, cells were transfected a second time with the
corresponding siRNA. After another 72h, the cells were
harvested using trypsin and were lysed as follows. For
Western blot analysis and the 2-Cys Prx redox blot, the
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proteins were alkylated for 30min at 37°C with 100mM
N-ethyl maleimide (NEM) (Pierce, St. Leon-Rot, Germany)
in PBS prior to lysis and were then lysed for 30min at room
temperature in 2% CHAPS lysis buﬀer containing 5mM
NEM (40mM HEPES, 50mM NaCl, 1mM EDTA, 1mM
EGTA, 1-fold protease inhibitor). For the intermediate trap-
ping, cells and also the brain tissue were lysed in NP40 lysis
buﬀer (10mM Tris, 10mM NaCl, 3mM MgCl2, 0.1%
NP40, pH7.4).
2.4. SDS PAGE and Western Blot. The protein concentration
of the clariﬁed lysates was determined using the Bradford
reagent (Bio-Rad, Hercules, USA). The proteins were diluted
in TE buﬀer (10mM Tris, 1mM EDTA, pH8) and mixed
with sample buﬀer. 20-40μg proteins were separated by
reducing (100mM DTT) or nonreducing SDS PAGE for
30min at 200V using a 4-20% Mini PROTEAN TGX stain-
free gel, which was subsequently activated according to the
manufacturer’s protocol, using the ChemiDoc XRS+ System.
The proteins were transferred to a PVDF membrane using
the Trans-Blot Turbo RTA Transfer Kit, according to the
manufacturer’s instructions. Using the ChemiDoc, the
transferred proteins were imaged. This picture was used to
normalize the Western blot signals to the total protein
amount of the sample separated during the SDS PAGE. The
membrane was blocked and incubated overnight with the
speciﬁc primary antibody. The membrane was washed and
incubated with HRP-coupled secondary antibody. The mem-
brane was incubated with SuperSignal West Pico/Femto
(Thermo Fisher Scientiﬁc, Waltham, USA) according to the
manufacturer’s instruction, to allow the detection of the
resulting chemiluminescence with the ChemiDoc system.
Western blots were densitometrically analyzed using ImageJ.
In the case of the 2-Cys Prx redox blot, cells were treated with
NEM prior and during cell lysis, and clariﬁed lysates were
subjected to nonreducing SDS PAGE andWestern blot using
speciﬁc antibodies against Prx1 and Prx2. The redox state of
Prxs was quantiﬁed using ImageJ. The ratio of the reduced
monomeric protein and the oxidized dimeric protein was
analyzed. The 2-dimensional diagonal redox SDS PAGE
was performed modifying the protocol described in [15]. In
brief, 40μg cell lysate was mixed with sample buﬀer,
denatured, and separated using a 4-20% PROTEAN TGX
stain-free gel (Bio-Rad) at 200V for 30min. The protein lane
was cut out and reduced in 250mM DTT in sample buﬀer at
65°C. The proteins were alkylated for 20min using 100mM
NEM in 1-fold sample buﬀer. Next, the gel was applied to a
second 4-20% PROTEAN TGX IPG gel. A molecular weight
marker was added, and the gel lane was overlayed with 1%
agarose before the proteins were separated again. Follow-
ing Western blotting, the total protein in the diagonal
was visualized using the stain-free technology with the
ChemiDoc XRS+ System. Pictures of the total protein in
the diagonal (depicted in blue) and the speciﬁc protein
of interest (in black) were overlayed using ImageLab 5.0
Software (Bio-Rad).
2.5. Immunocyto- and Histochemistry. Immunocyto- and
histochemistry were performed as described in [5, 16].
The samples were analyzed with a Leica LCS SP2 confocal
microscope (Leica, Wetzlar, Germany). Deconvolution and
colocalization analysis was performed with the Huygens
software package (Scientiﬁc Volume Imaging, Hilversum,
Netherlands).
2.6. Intermediate Trapping and Mass Spectrometry. 1.5 g
CNBr-activated sepharose (GE Healthcare, Little Chalfont,
UK) was prepared for coupling according to the manufac-
turer’s protocol. 1.17mg puriﬁed mNrx Cys208Ser was
rebuﬀered with coupling buﬀer (0.1M NaHCO3, 0.5MNaCl,
pH8.3) using a PD-10 Sephadex G-25 column (GE Health-
care, Little Chalfont, UK) and added to the sepharose for
6 h at 4°C. After blocking the column overnight with 300μl
blocking buﬀer (50mM NaH2PO4, 1mM ethanolamine,
1mM HCl) and washing it with excess TE buﬀer, the protein
was reduced adding 10mM DTT in TE buﬀer (10mM Tris,
1mM EDTA, pH8), followed by washing with TE buﬀer.
After equilibrating the sepharose with 5ml NP40 lysis buﬀer,
3ml clariﬁed SH-SY5Y lysates or mouse brain extracts were
added to the column and incubated for 2 h at 4°C. Mouse
brain extracts were isolated from Black 6 C57J mice, homog-
enized, and lysed in NP40 lysis buﬀer. The column was
washed ﬁrst with Tris buﬀer (100mM Tris, 300mM NaCl,
pH8) and then with TE buﬀer, before trapped proteins were
eluted in 5ml 10mM DTT and 10mM neutralized TCEP. A
washing step with 3ml TE buﬀer yielded a second eluate. The
eluates were combined, and proteins were precipitated
adding 10% TCA (ﬁnal) (Roth, Karlsruhe, Germany). The
proteins were pelletized by centrifugation (13300 rpm,
50min, 4°C) and washed once with ice-cold 100% acetone
(Roth, Karlsruhe, Germany) and twice with 80% (room tem-
perature) acetone. Between the washing steps, the proteins
were centrifuged for 45min at 13300 rpm and 4°C. One part
of the pellet was resuspended in 100μl urea buﬀer (8M urea,
20mM HEPES, 1mM EDTA, pH8) and separated using a
Mini-PROTEAN TGX stain-free gel (Bio-Rad, Hercules,
USA) at 100V for one hour. The PageBlue (Fermentas, St.
Leon-Rot, Germany) stained gel was analyzed via mass
spectrometry, as well as a part of the pure, nonresuspended
protein pellet. Supplementary Figure 2 shows a scheme
depicting the intermediate trapping approach.
2.7. Diﬀerential Thiol-Redox Labeling with iodoTMT. Diﬀer-
ential labeling was performed as described before in [17]. In
brief, Nrx-depleted SH-SY5Y cells and scrambled siRNA
control cells were harvested, washed with PBS, and lysed by
sonication in UHE buﬀer (8M urea, 20mM HEPES, 1mM
EDTA, pH8.0) containing one vial of iodoTMT™ labeling
reagent, see Table 1 (Thermo Fisher Scientiﬁc, Waltham,
USA), followed by incubation for 1 h at 30°C. The lysate
was cleared, and proteins were acetone-precipitated. The pre-
cipitate was pelleted and washed with acetone, and the air
dried pellet was dissolved, reduced, and alkylated in 100μl
UHT buﬀer (8M urea, 20mM HEPES pH8.0, 1mM
TCEP) containing a second vial of the iodoTMT™ labeling
reagent, followed by incubation for 1 h at 30°C. The protein
concentration was determined, equal protein amounts of
three biological replicates were mixed, and proteins were
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acetone-precipitated. The pellet was washed with acetone,
and the air-dried pellet was loosened in 25mM ammonium
bicarbonate buﬀer and digested for 2 h at 30°C adding trypsin
at a protein to enzyme ratio of 100 : 1. The same amount of
trypsin as before was added a second time, and the sample
was incubated overnight at 30°C. The reaction was stopped
by adding triﬂuoroacetic acid (TFA), and the proteins were
freeze-dried. The pellets were dissolved in TBS, and the
iodoTMT™ labeled peptides were puriﬁed using an anti-
TMT™ antibody (Thermo Fisher Scientiﬁc, Waltham,
USA). The peptides were eluted adding 400μl TMT (tandem
mass tag) elution buﬀer (Thermo Fisher Scientiﬁc, Waltham,
USA), followed by centrifugation. The supernatant was
freeze-dried and dissolved in 5% acetonitrile/0.1% TFA.
The samples were desalted via stage tipping. The peptides
were separated with nano-HPLC and analyzed with an
in-line coupled high-accuracy mass spectrometer. Spectra
were analyzed with the computational proteomics platform
MaxQuant with integrated quantiﬁcation algorithms for
chemical labels. Supplementary Figure 1 shows a scheme
of the diﬀerential labeling approach.
The iodoTMT™ labels were also used to analyze changes
in the abundance of proteins with cysteinyl residues. To do
so, the samples were treated as described before except that
the TCEP was already added to the lysis buﬀer with
iodoTMT™ reagent to label all thiols in one step.
2.8. Functional Annotation Analyses. Gene ontology (GO)
analysis and classiﬁcation was done using the PANTHER
data analysis and classiﬁcation system. Proteins identiﬁed
in the diﬀerential labeling approach with a p value< 0.05
and identiﬁed proteins from the intermediate trapping
approaches with at least two determined iBAQs (intensity-
based absolute quantiﬁcation) were loaded separately into
the classiﬁcation tool. Proteins were analyzed for the ontol-
ogies’ “biological process” and “molecular function” using a
human background for the diﬀerential labeling and the inter-
mediate trapping with SH-SY5Y extracts and a mouse back-
ground for the intermediate trapping data gained with mouse
brain extracts.
3. Results and Discussion
Nrx is an active oxidoreductase that catalyzes thiol-disulﬁde
exchange reactions in vitro [6]. It was shown to act as a signal
transducer in some pathways, e.g., Wnt/Dvl [12]; however,
no comprehensive analysis of its substrates and regulated
pathways was available.
We applied two distinct strategies for the identiﬁcation of
Nrx targets. First, we performed a diﬀerential thiol-labeling
approach that allows the speciﬁc analysis of the redox state
of the whole thiol-redox proteome. We compared cells with
siRNA-mediated silencing of Nrx expression to control cells
treated with unspeciﬁc scrambled siRNA (see Supplementary
Fig. 1). Second, we used an active site mutant of Nrx that
lacks the C-terminal resolving cysteinyl residue within the
dithiol active site motif. This protein was immobilized and
allowed to react with potential target proteins. The thiol-
disulﬁde exchange reaction mechanism of Trx family pro-
teins requires the formation of an intermediate mixed disul-
ﬁde of the N-terminal active site cysteinyl residue with the
target protein. This intermediate is trapped in reactions with
the mutant protein; hence, we named this approach interme-
diate trapping [18] (see Supplementary Fig. 2). We focused
on redox-regulated targets in neuronal cells. Next to brain
tissue from 6-week-old mice, we analyzed the cell line SH-
SY5Y that was originally derived from a female patient with
neuroblastoma. These cells display a high dopamine-β-
hydroxylase activity and are able to form processes resem-
bling dendrites and axons [19].
Nrx-speciﬁc RNA interference was established compar-
ing three diﬀerent siRNAs. All of them were eﬀective in
signiﬁcantly reducing the levels of Nrx in HeLa cells
(Figures 1(a) and 1(b)). The most eﬀective one (siRNA C)
reduced the levels of Nrx after consecutive rounds of trans-
fections to below 3% compared to control-transfected cells
and was used for further experiments. The eﬃciency of the
knockdown was also conﬁrmed in SH-SY5Y cells, where
the protein was essentially undetectable following the siRNA
treatment (Figure 1(c)).
Nrx was described to act in both the nucleus [6] and
cytosol, e.g., [12]. To clarify the localization of the protein
in neuronal cells, we have analyzed the subcellular locali-
zation of the protein in both neuron-like SH-SY5Y cells
and dopaminergic cells of the mouse substantia nigra by
immunocyto- and histochemistry and confocal microscopy
(Figure 2). In all analyzed cells, Nrx displayed a dual nuclear
and cytosolic staining. This conﬁrms previous results from
our extensive analysis of redoxins in mouse tissues [5],
as well as the data presented in the human protein atlas
[20] (https://proteinatlas.org).
To analyze the thiol proteome in Nrx-depleted cells,
SH-SY5Y cells were transfected and seeded in ﬂasks for the
labeling steps. For each condition, the siRNA-mediated
gene-silencing of Nrx was conﬁrmed by Western blot analy-
sis (not shown). The samples were subjected to the diﬀeren-
tial labeling as described and analyzed by quantitative mass
spectrometry; for details, see the experimental procedures,
Table 1, and Supplementary Fig. 1. To our surprise, 161,
i.e., 94.2%, of the 171 proteins identiﬁed with signiﬁcant
changes of the thiol-redox state were more reduced in the
samples lacking Nrx expression (Figure 2(a)). These proteins
displayed changes in at least one cysteinyl-containing
peptide. The full list of these proteins was included in the
supplementary material. These unexpected results suggest
that Nrx may be involved in the oxidation of these proteins
in vivo. The oxidation of protein thiols under physiological
Table 1
Sample 1st label (reduced) 2nd label (oxidized) Full label
siCtrl 1 126 129 126
siCtrl 2 127 130 127
siCtrl 3 128 131 128
siNrx 1 126 129 129
siNrx 2 127 130 130
siNrx 3 128 131 131
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conditions is still a mystery. Although hydrogen peroxide
can facilitate this, the low rate constants of most protein
thiols with H2O2 preclude that this reaction occurs in vivo
[2, 21, 22]. This led to the proposal that thiol- and selenol-
peroxidases may act as sensors or transmitters by transfer-
ring the disulﬁdes that form within their active site following
the reduction of peroxides to speciﬁc target proteins [21].
Thiol-disulﬁde exchange reactions are fully reversible by
nature. The direction of these reactions is determined by
thermodynamic constrains such as the redox potential. The
velocity of the reactions, however, is determined by the
activity of enzymes that catalyze the reactions [22]. In fact,
recent reports demonstrated that the oxidation of various
protein thiols in cells depends on the presence of active per-
oxiredoxins [15]. It is tempting to speculate about a catalytic
function of Nrx in disulﬁde relay pathways. In fact, we iden-
tiﬁed Prx1 as an interaction partner of Nrx in this study.
To analyze the potential role of Nrx as oxidase of protein
thiols also in cells of nonneuronal origin, we determined the
redox state of both Prx1 and Prx2 in the HeLa cells lacking
Nrx using Western blotting following nonreducing SDS
PAGE (Figure 3). Prxs form an intermolecular disulﬁde in
their reaction cycle that allows determining their redox state
in samples treated with thiol alkylators during the harvesting
and lysis of cells. Prx1, but not Prx2, was slightly more oxi-
dized in the absence of Nrx, 11.1% compared to 7.2% in con-
trols. Albeit statistical power was low (p value = 0.1, unpaired
t-test analysis) (Figures 3(a) and 3(b)), the more oxidized
Prx1 and the more reduced target proteins support the idea
that Prx1 may oxidize Nrx in diﬀerent cell types. Subse-
quently, Nrx transfers these oxidation equivalents to other
proteins that cannot directly interact with the Prx.
Next to the diﬀerences in the redox state, the levels of 58
proteins were signiﬁcantly altered, i.e., the p value of three
independent samples was lower than 0.05. 30 of these pro-
teins were decreased in the cells lacking Nrx compared to
the control cells (see supplementary material).
For the second approach, we cloned mouse Nrx, pro-
duced the trapping mutant protein Cys208Ser by PCR, and
puriﬁed the protein by metal aﬃnity chromatography follow-
ing recombinant expression in E. coli (see supplementary
Figures 2 and 3). The proteins were immobilized and
allowed to react with potential targets that were identiﬁed
by mass spectrometry. The intermediate trapping of
potential targets from mouse brain tissue as well as from


















































Figure 1: Establishment of siRNA-mediated gene-silencing in HeLa cells. Three diﬀerent siRNAs against Nrx (siNrx A-C) as well as
unspeciﬁc control siRNA (siCtrl) were used to establish a speciﬁc gene-silencing of Nrx. HeLa cells were transfected twice by
electroporation, and 72 h after each transfection, cell extracts were prepared. The Nrx protein levels were analyzed by immunoblotting
using speciﬁc antibodies against Nrx and actin (a). The quantiﬁcation of the Western blot signals was performed using ImageJ and shows
that siNrx C induced the most eﬃcient knockdown of Nrx (b). Conﬁrmation of the siRNA-mediated knockdown of Nrx in SH-SY5Y cells
(n = 3) (c).
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hits, respectively, in the databases. In contrast to the
diﬀerential labeling approach, however, this approach does
not allow concluding the direct or indirect reduction or
oxidation of target proteins by Nrx due to the reversibility
of the thiol-disulﬁde exchange reactions. The full lists of the
identiﬁed proteins were also included in the supplementary
material.
51 potential Nrx target proteins were identiﬁed by all
three approaches and are listed in Table 2. Also, the analysis
of the aﬀected biological processes and molecular functions
using the PANTHER data analysis and classiﬁcation system
[23, 24] yielded a high degree of overlap between the diﬀerent
experiments; see Figures 2(b) and 2(c). The lists are topped
by cellular/metabolic processes and proteins with enzymatic
activity, e.g., glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) or triose phosphate isomerase. These are followed
by structural proteins, many of which function in a cellular
component organization, e.g., coﬁlin 1, fascin 1, or kinesin
light chain 1. Also, proteins with functions in the regulation
of cellular processes and signal transduction were identiﬁed
in signiﬁcant numbers, for instance, guanine nucleotide-
binding protein 1 or histone deacetylase 2.
Some of the proteins identiﬁed here as potential Nrx




Figure 2: Subcellular localization of Nrx in SH-SY5Y cells and dopaminergic neurons of the mouse CNS. Immunocytochemistry stained for
Nrx (green) and nuclei (blue in (b) and (d)) or tyrosine hydroxylase (yellow in (f)), analyzed by confocal microscopy. (a, b) SH-SY5Y control
cells. (c, d) SH-SY5Y cells 72 hours after the beginning of neuron-like diﬀerentiation induced by retinoic acid. (e, f) Nrx staining in the
substantia nigra of the mouse; dopaminergic neurons were labeled for tyrosine hydroxylase (yellow).
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thiol-redox state. GAPDH, for instance, is inactivated by
disulﬁde formation and other redoxmodiﬁcations of its active
site Cys152 [25]. Here, we found this cysteinyl residue to be
slightly more reduced (3.4%; p value 0.031) in the absence of
Nrx in the cells of neuronal origin (see Supplementary
Tables). We have also analyzed the redox state of this protein
in the HeLa cell culture model using a 2-dimensional diago-
nal gel electrophoresis approach as described in [15]
(Figures 4(c) and 4(d)). The protein was more oxidized in
the presence of Nrx, as seen from the increased GAPDH
staining below the diagonal (Figure 4(c)), compared to cells
lacking Nrx (Figure 4(d)). Coﬁlin 1 was reported to be redox
regulated by both glutathionylation [26] and intermolecular
disulﬁde formation [27]. The protein seems to be inhibited
by oxidation in its regulation of actin dynamics. Cell migra-
tion, for instance, seems to require the reduction of the
protein [28]. We have conﬁrmed the more reduced state of
coﬁlin 1 also in the HeLa model using diagonal
5.8%
94.2%
161 of 171 proteins
more reduced





















































































































Figure 3: Classiﬁcation of potential Nrx interaction partners identiﬁed by mass spectrometric analysis. To identify potential Nrx interaction
partners and targets, three mass spectrometric-based approaches were performed, namely, a diﬀerential labeling with neuroblastoma
SH-SY5Y cells lacking Nrx as well as two intermediate trappings (IT) with recombinant mNrx Cys208Ser using SH-SY5Y cell and mouse
brain extracts. The results from the diﬀerential labeling were used to analyze the redox proteome of Nrx-depleted cells revealing that
94.2% of the identiﬁed cysteine-containing proteins were more reduced in the absence of Nrx (a). The potential interaction partners of
Nrx, identiﬁed by all three approaches, were compared regarding their biological processes (b) and their molecular function (c) using the
PANTHER classiﬁcation system. There is a big resemblance between the results of the three approaches, with most potential interaction
partners having catalytic activities and functions in binding, as well as metabolic and cellular processes.
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electrophoresis (Figures 4(e) and 4(f)). Nrx appears to
promote the intermolecular disulﬁde-bonded form of coﬁlin
1 (Figure 4(e)). Hence, Nrx may, through the oxidation
and inhibition of coﬁlin 1, negatively regulate cytoskelatal
dynamics and cell motility.
One of the proteins with the most substantial changes in
thiol-redox state was the triose phosphate isomerase. In the
absence of Nrx, four cysteinyl residues were found to be more
reduced: Cys67 (38.9%, p value 0.0385), Cys87 (29.4%,
p value 0.0245), Cys127 (42.1%, p value 0.0125), and Cys218
(38.7%, p value 0.0479). The S-nitrosylation of the latter
Cys218 residue has been reported to lead to a reduction in
the activity of the human protein by 30% [29]. The glutathio-
nylation of the human enzyme has been described in stressed
T-lymphocytes [26]. In the close homologous enzymes from
plants and algae, Cys127 and Cys218 can also be modiﬁed
by glutathionylation [30] and other redox modiﬁcations
(summarized, e.g., in [31]). The branched-chain amino
acid aminotransferase was reported to be inactivated by
S-nitrosylation and S-thiolation [32, 33]. In the absence
of Nrx, we found the protein to be more reduced at
Cys292 (20.1%, p value 0.044). Among the proteins identi-
ﬁed here that were not yet reported to be regulated by
redox modiﬁcation of cysteinyl residues were the proteaso-
mal subunit PSMA6 that was more reduced in the absence
of Nrx at Cys47 (31.4%, p value 0.0238) and the dynein
light chain 1 that was more reduced at Cys56 (23.8%,
p value 0.0177). One of the few proteins that was signiﬁ-
cantly more oxidized in the absence of Nrx was the glutathi-
one S-transferase omega 1 (13.4%, p value 0.0392) at the
nonactive site residue Cys159.
We also identiﬁed proteins that were described as inter-
action partners of Nrx before. Nrxs suggested an electron
donor in thiol-disulﬁde exchange reactions; the selenopro-
tein thioredoxin reductase 1 (TrxR1) [6] was identiﬁed in
all three experiments. Protein phosphatase 2A was shown
to form a stable complex with Nrx that may be important
for the regulation of its activity [7]. In our diﬀerential labeling
Table 2: Potential Nrx targets identiﬁed by all three approaches.
The table contains the 51 proteins that were identiﬁed in all three
experiments, i.e., the diﬀerential thiol labeling in Nrx-depleted
SH-SY5Y cells, and the intermediate trapping using SH-SY5Y and
mouse brain extracts. The proteins are sorted alphabetically; full
lists can be found in the supplementary material.
Protein ID Gene name Protein name





P04075 ALDOA Fructose-bisphosphate aldolase A




P78371 CCT2 T-Complex protein 1 subunit beta
P50990 CCT8 T-Complex protein 1 subunit theta
P23528 CFL1 Coﬁlin-1




P26641 EEF1G Elongation factor 1-gamma







P62873 GNB1 Guanine nucleotide-binding protein








P07900 HSP90AA1 Heat shock protein HSP 90-alpha




Q07866 KLC1 Kinesin light chain 1
P28838 LAP3 Cytosol aminopeptidase
P55209 NAP1L1 Nucleosome assembly protein 1-like 1
P12955 PEPD Xaa-Pro dipeptidase
P14618 PKM Pyruvate kinase
P62937 PPIA Peptidyl-prolyl cis-trans isomerase A
P53041 PPP5C Serine/threonine-protein phosphatase 5
Q06830 PRDX1 Peroxiredoxin-1
Q9H6Z4 RANBP3 Ran-binding protein 3
P54136 RARS Arginine-tRNA ligase, cytoplasmic
P39023 RPL3 60S ribosomal protein L3
P36578 RPL4 60S ribosomal protein L4
P61247 RPS3A 40S ribosomal protein S3a
Q16181 SEPT7 Septin-7
Table 2: Continued.
Protein ID Gene name Protein name
P37837 TALDO1 Transaldolase
P60174 TPI1 Triosephosphate isomerase
Q71U36 TUBA1A Tubulin alpha-1A chain
Q9BVA1 TUBB2B Tubulin beta-2B chain
Q16881 TXNRD1 Thioredoxin reductase 1, cytoplasmic
P62987 UBA52 Ubiquitin-60S ribosomal protein L40
P61088 UBE2N Ubiquitin-conjugating enzyme E2 N
P45974 USP5 Ubiquitin carboxyl-terminal hydrolase 5
Q99536 VAT1





P54577 YARS Tyrosine-tRNA ligase, cytoplasmic
P63104 YWHAZ
14-3-3 protein zeta/delta
(protein kinase C inhibitor protein 1)
8 Oxidative Medicine and Cellular Longevity
approach, protein phosphatase 2C A was one of the few pro-
teins that was more oxidized in the presence of Nrx (Cys266,
6.6%, p value 0.0258). Interestingly, in plant cells, catalase is
maintained in a reduced state by substrate-interaction with
the Nrx homologue NRX1 [34].
Nrx has been implied in the redox regulation of
cellular diﬀerentiation through the Wnt signaling pathway
[10–12]. Our study suggests that it may also function in
neuronal development. Reactive oxygen species and the
redox state of various proteins contribute to neurogenesis,
cell polarization, and maturation of neurons, providing a
context for the spatiotemporal control of neural fate; see,
for instance, [35]. The production of hydrogen peroxide is














































































Figure 4: Redox state of cytosolic peroxiredoxins, coﬁlin, and GAPDH in Nrx-depleted HeLa cells. The redox state of Prx1 and Prx2 was
analyzed in Nrx-depleted HeLa cells by 2-Cys Prx redox blot (a). Prior to lysis, free thiols were alkylated with NEM, and the monomer
and dimer levels of the two proteins were analyzed via the 2-Cys Prx redox blot using speciﬁc antibodies against Prx1 and Prx2,
respectively (a). The quantiﬁcation of the Western blot signals using ImageJ (b) shows that more dimeric, i.e., oxidized Prx1, is present in
the absence of Nrx (p value = 0.1). (c-f) Analysis of the redox state of potential Nrx targets by 2-dimensional diagonal gel electrophoresis
and Western blotting. Both GAPDH and coﬁlin showed an increased staining of spots that fell below the diagonal in the second
dimension in the presence of Nrx (c, e), compared to HeLa cells lacking Nrx (d, f). In the overlayed pictures, the total protein content in
the diagonal is depicted in blue, the speciﬁc protein of interest in black.
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[21, 22]. Nucleoredoxin may thus be a facilitator of hydro-
gen peroxide signaling by catalyzing the thiol-disulﬁde
exchange reaction between peroxidases, such as Prxs, as
sensors and the downstream target proteins that mediate
the biological functions.
In summary, our study presented here suggests a number
of speciﬁc functions for mammalian Nrx in the redox reg-
ulation of metabolic pathways, cellular morphology, and
signal transduction pathways in neuronal cells. We identi-
ﬁed numerous proteins with an altered thiol-redox state,
dependent on the presence of Nrx. Astonishingly, most
of these thiols were more reduced in the absence of this
Trx family oxidoreductase. These results suggest a function
of Nrx in the oxidation of these thiols, rather than their
reduction. A possible way for the oxidation of Nrx itself
may be the formation of disulﬁde relays with peroxiredox-








PDI: Protein disulﬁde isomerase
Prx: Peroxiredoxin
TMT: Tandem mass tag
Trx: Thioredoxin.
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